nilotinib

The medicine is used to treat adults and children and adolescents suffering from Philadelphia chromosome-positive chronic myeloid leukemia (CML Ph+). It is intended for individuals with newly diagnosed disease or for those for whom previous treatment has ceased to be effective or has caused severe side effects.

Form: capsules, hard

ATC: L01EA03

Manufacturer: Clonmel Healthcare Ltd. Pharos Pharmaceutical Oriented Services Ltd. STADA Arzneimittel AG STADA Arzneimittel GmbH

The medicine is used to treat Philadelphia chromosome-positive chronic myeloid leukemia (CML Ph+) in adults, as well as in children and adolescents with newly diagnosed disease or in patients for whom previous treatment has not been effective or has caused severe side effects.

Form: capsules, hard

ATC: L01EA03

Manufacturer: Clonmel Healthcare Ltd. Pharos Pharmaceutical Oriented Services Ltd. STADA Arzneimittel AG STADA Arzneimittel GmbH

The medicine is used to treat Philadelphia chromosome-positive chronic myeloid leukemia (CML Ph+) in adults, as well as in children and adolescents with newly diagnosed disease or in patients for whom previous treatment has not been effective or has caused severe side effects.

Form: capsules, hard

ATC: L01EA03

Manufacturer: Clonmel Healthcare Ltd. Pharos Pharmaceutical Oriented Services Ltd. STADA Arzneimittel AG STADA Arzneimittel GmbH

This medicine is used to treat adults as well as children and adolescents with Philadelphia chromosome-positive chronic myeloid leukemia (CML Ph+). It helps to stop the production of abnormal white blood cells.

Form: capsules, hard

ATC: L01EA03

Manufacturer: PharOS Mt Ltd Pharos Pharmaceutical Oriented Services Ltd.

The medicine is used to treat adults as well as children and adolescents suffering from Philadelphia chromosome-positive chronic myeloid leukemia (CML Ph+). It is intended for individuals with newly diagnosed disease and for patients for whom previous treatment has not been effective or has caused severe side effects.

Form: capsules, hard

ATC: L01EA03

Manufacturer: PharOS Mt Ltd Pharos Pharmaceutical Oriented Services Ltd.

The medicine is used to treat adults as well as children and adolescents suffering from Philadelphia chromosome-positive chronic myeloid leukemia (CML Ph+). It may be used in patients with newly diagnosed disease or in those for whom previous treatment has stopped working or has caused severe side effects.

Form: capsules, hard

ATC: L01EA03

Manufacturer: PharOS Mt Ltd Pharos Pharmaceutical Oriented Services Ltd.

This medicine is used to treat adults, as well as children and adolescents suffering from chronic myeloid leukemia with the Philadelphia chromosome (CML Ph+). It may be used in patients with newly diagnosed disease or in patients for whom previous treatment has ceased to be effective or has caused severe side effects.

Form: capsules, hard

ATC: L01EA03

Manufacturer: PharOS MT Ltd. Pharos Pharmaceutical Oriented Services Ltd.

This medicine is used to treat chronic myeloid leukemia with the Philadelphia chromosome (CML Ph+). It is intended for adults as well as children and adolescents for whom previous treatment has not been effective or has caused severe side effects.

Form: capsules, hard

ATC: L01EA03

Manufacturer: PharOS MT Ltd. Pharos Pharmaceutical Oriented Services Ltd.